New study maps best antibiotic steps for fever in cancer patients

NCT ID NCT07204522

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a specific order of antibiotics for cancer patients who develop fever due to low white blood cells (febrile neutropenia). Twenty adults with blood cancers will receive a carbapenem first, then add vancomycin or linezolid if fever persists, and finally an antifungal if needed. The goal is to see how well this step-up plan controls fever and infection, and to monitor for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Carbapenems, vancomycin, linezolid, antifungal agents, ceftazidime-avibactam, aztreonam
What this could lead to
If successful, this could establish a clear, effective treatment roadmap for managing fever in cancer patients with weakened immune systems, potentially reducing complications.
What could go wrong
This is a small, early observational study with only 20 participants, so results may not apply to all patients. The step-up approach may not work for everyone and carries risks like side effects from multiple antibiotics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanxi Bethune Hospital

    RECRUITING

    Taiyuan, Shanxi, 030000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.